NCT00006486View on ClinicalTrials.gov

Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

335

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

October 31, 2005

Conditions
Recurrent Renal Cell CancerStage IV Renal Cell Cancer
Interventions
DRUG

carboxyamidotriazole

Given orally

OTHER

placebo

Given orally

Trial Locations (1)

60606

Cancer and Leukemia Group B, Chicago

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00006486 - Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer | Biotech Hunter | Biotech Hunter